GSTM1 and Schnyder corneal dystrophy: The Comprehensive Study of Sickle Cell Disease (CSSCD) cohort study demonstrated that the median survival for men and women was 42 and 48 years in Hb SS SCD and 60 and 68 years in Hb SC SCD, respectively [4].